Evidence map›Paper›PMID 25074925›Full record

ArticleThe Journal of biological chemistry2014

Pharmacological profile of brain-derived neurotrophic factor (BDNF) splice variant translation using a novel drug screening assay: a "quantitative code".

Valentina Vaghi, Alessio Polacchini, Gabriele Baj, Vera L M Pinheiro, Annalisa Vicario, Enrico Tongiorgi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. High throughput assay for compounds that boost BDNF expression in neurons.SLAS discovery : advancing life sciences R & D · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Valentina VaghiFrom the Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Alessio PolacchiniFrom the Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Gabriele BajFrom the Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Vera L M PinheiroFrom the Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Annalisa VicarioFrom the Department of Life Sciences, University of Trieste, 34127 Trieste, Italy.
Enrico TongiorgiFrom the Department of Life Sciences, University of Trieste, 34127 Trieste, Italy tongi@units.it.
University of Trieste · IT

Funding

Telethon GGP08258
6 · The paper itself

Abstract

The neurotrophin brain-derived neurotrophic factor (BDNF) is a key regulator of neuronal development and plasticity. BDNF is a major pharmaceutical target in neurodevelopmental and psychiatric disorders. However, pharmacological modulation of this neurotrophin is challenging because BDNF is generated by multiple, alternatively spliced transcripts with different 5'- and 3'UTRs. Each BDNF mRNA variant is transcribed independently, but translation regulation is unknown. To evaluate the translatability of BDNF transcripts, we developed an in vitro luciferase assay in human neuroblastoma cells. In unstimulated cells, each BDNF 5'- and 3'UTR determined a different basal translation level of the luciferase reporter gene. However, constructs with either a 5'UTR or a 3'UTR alone showed poor translation modulation by BDNF, KCl, dihydroxyphenylglycine, AMPA, NMDA, dopamine, acetylcholine, norepinephrine, or serotonin. Constructs consisting of the luciferase reporter gene flanked by the 5'UTR of one of the most abundant BDNF transcripts in the brain (exons 1, 2c, 4, and 6) and the long 3'UTR responded selectively to stimulation with the different receptor agonists, and only transcripts 2c and 6 were increased by the antidepressants desipramine and mirtazapine. We propose that BDNF mRNA variants represent "a quantitative code" for regulated expression of the protein. Thus, to discriminate the efficacy of drugs in stimulating BDNF synthesis, it is appropriate to use variant-specific in vitro screening tests.

Indexed as

Alternative SplicingDrug Evaluation, PreclinicalPeptide Chain Elongation, Translational3' Untranslated Regions5' Untranslated RegionsAntidepressive AgentsBrain-Derived Neurotrophic FactorGenes, ReporterHumansRNA, Messenger3' Untranslated Regions5' Untranslated RegionsAntidepressive AgentsBrain-Derived Neurotrophic FactorRNA, MessengerBrain-derived Neurotrophic Factor (BDNF)Drug ScreeningIn Vitro AssayNeurotransmitterSignalingSplice VariantsTranslation

Identifiers

PMID25074925
PMCPMC4183807
OpenAlexW2006934911

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.